ArticleActa haematologica2025

Anexelekto (Axl)/Mer Inhibitor Tamnorzatinib in Patients with Relapsed/Refractory Acute Myeloid Leukaemia: Results from a Phase I (Monotherapy) and Phase II (Combination with Venetoclax) Clinical Study.

Margaret T Kasner et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.